Stock Comparison

EXEL vs REGN

Exelixis Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

EXEL

Exelixis Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$13.77B

$66.35B

P/E (TTM)

18.1

15.5

Forward P/E

16.8

14.1

Price/Sales

5.8

4.5

Price/Book

6.9

2.1

EV/EBITDA

13.0

10.5

Dividend Yield

—

0.58%

Profitability

Net Margin

35.10%

29.60%

Operating Margin

41.10%

20.70%

Return on Equity

41.00%

14.50%

Return on Assets

22.00%

6.13%

Growth (YoY)

Revenue Growth

10.00%

19.00%

Earnings Growth

43.60%

-7.20%

Price & Risk

Beta

0.4

0.2

52-Week High

$55.15

$818.90

52-Week Low

$33.76

$516.07

Analyst Target

$49.50

$833.31

Compare EXEL and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.